BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bonilla CM, McGrath NA, Fu J, Xie C. Immunotherapy of hepatocellular carcinoma with infection of hepatitis B or C virus. Hepatoma Res. 2020;6. [PMID: 33134550 DOI: 10.20517/2394-5079.2020.58] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Granito A, Muratori L, Lalanne C, Quarneti C, Ferri S, Guidi M, Lenzi M, Muratori P. Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment. World J Gastroenterol 2021; 27(22): 2994-3009 [PMID: 34168403 DOI: 10.3748/wjg.v27.i22.2994] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 41] [Article Influence: 46.0] [Reference Citation Analysis]
2 Singh B, Kaur P, Maroules M. Hyperprogression in a Patient With Hepatocellular Cancer Treated With Atezolizumab and Bevacizumab: A Case Report and Review of Literature. J Investig Med High Impact Case Rep 2021;9:2324709621992207. [PMID: 33787380 DOI: 10.1177/2324709621992207] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]